Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
Prometheus Biosciences (RXDX) - Total assets
Total assets on the balance sheet as of March 2023 : $0.75 B
According to Prometheus Biosciences's latest financial reports the company's total assets are $0.75 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Prometheus Biosciences - Total assets on balance sheet (from 2020 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.74 B | 176.61% |
| 2021-12-31 | $0.26 B | 349.08% |
| 2020-12-31 | $59.63 M | 18.12% |
| 2019-12-31 | $50.48 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Epizyme EPZM | N/A | N/A | 🇺🇸 USA |
 Akebia Therapeutics AKBA | $0.24 B | -68.13% | 🇺🇸 USA |
 Agenus
AGEN | $0.31 B | -58.61% | 🇺🇸 USA |